At the 2014 Pharma Compliance Europe event, Michael Harris, Head of Enhanced Due Dilligance-EMEA, Thomson Reuters, gave the presentation “Effective third party due diligence for Pharma companies: understanding current trends and issues.”
Download and learn:
- Who are we dealing with?
- Detailed accurate reliable intelligence
- Types of risks faced in the pharma and medical device industry in China
- Top countries for enhanced due diligence screening
- Issues facing the pharma industry
- Third party assessment
- The basic questions
- A structured risk based approach to due diligence
- Penalties of getting it wrong
- Conclusions
Download Presentation
Found this interesting? You might also be interested in our Pharma Compliance Europe 2015 event, taking place 7-8 October in London. Find out more